Alpa Laboratories — 360° view

Alpa Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹31 crore and a net loss of ₹1.85 crore for the September 2026 quarter.

Alpa Laboratories (NSE: ALPA) closed at ₹49.92 on 20 Nov 2026, down 37.1% over the past year. Its market capitalisation is ₹105 crore and it trades at 50.0 times earnings.

Share price
₹49.92 (20 Nov 2026)
Market cap
₹105 Cr (20 Nov 2026)
P/E
50.02 (20 Nov 2026)
Revenue
₹31 Cr (September 2026 quarter)
Net profit
₹-2 Cr (September 2026 quarter)
ROCE
9.40% (FY26)
ROE
8.38% (FY26)
Book value
₹88.4 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹92.50 / ₹46.10 (20 Nov 2026)
1-year return
-37.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ALPA

Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.